Growth hormone used to control intractable bleeding caused by radiation-induced gastritis

Figure 1 Endoscopic view. A: Diffuse edematous hyperemia and active bleeding from the esophagus-stomach anastomosis after radiation therapy; B: An ulcer with bleeding in the antrum after radiation therapy; C: Active oozing of blood from the esophagus-stomach anastomosis after three months of anti-secretory therapy; D: An ulcer with active bleeding after three months of anti-secretory therapy; E: No active oozing of blood from the esophagus-stomach anastomosis two months after growth hormone therapy; F: An ulcer scar without active bleeding two months after growth hormone therapy.